SRRK

Scholar Rock Holding

• Simply Wall St·1d ago

  A Look At Scholar Rock (SRRK) Valuation After Apitegromab BLA Resubmission And Reduced Regulatory Risk

• TipRanks·04/01 17:00

  Analysts Offer Insights on Healthcare Companies: Scholar Rock Holding (SRRK) and Medtronic (MDT)

• TipRanks·04/01 16:50

  Scholar Rock price target raised to $57 from $54 at Jefferies

• Benzinga·04/01 13:56

  Scholar Rock To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday

• Dow Jones·04/01 12:49

  Scholar Rock Holding Is Maintained at Outperform by Wedbush

• Dow Jones·04/01 12:49

  Scholar Rock Holding Price Target Raised to $58.00/Share From $56.00 by Wedbush

• Benzinga·04/01 12:38

  Wedbush Maintains Outperform on Scholar Rock Holding, Raises Price Target to $58

• TipRanks·04/01 10:16

  De-Risked Regulatory Path and Manufacturing Readiness Underpin Buy Rating on Apitegromab

• TipRanks·04/01 09:21

  Analysts’ Top Healthcare Picks: Sotera Health (SHC), Insmed (INSM)

• Reuters·04/01 07:57

  U.S. RESEARCH ROUNDUP-Asana, PPG Industries, Verisign

• Reuters·04/01 03:28

  SCHOLAR ROCK HOLDING CORP <SRRK.O>: RAYMOND JAMES RAISES TARGET PRICE TO $60 FROM $53

• Simply Wall St·04/01 02:11

  Why Scholar Rock Holding (SRRK) Is Up 16.2% After Apitegromab BLA Resubmission With FDA-Aligned Manufacturing

• NASDAQ·03/31 22:20

  Stocks Surge on Signs the US and Iran Seek to End War

• Reuters·03/31 21:00

  Scholar Rock resubmits apitegromab BLA to FDA for spinal muscular atrophy treatment

• TipRanks·03/31 17:43

  Morning News Wrap-Up 3/31/26: Today’s Biggest Stock Market Stories!